Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosing, J.
Right arrow Articles by Zwaal, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosing, J.
Right arrow Articles by Zwaal, R. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

The role of activated human platelets in prothrombin and factor X activation

J Rosing, JL van Rijn, EM Bevers, G van Dieijen, P Comfurius and RF Zwaal

The effect of activated human platelets in intrinsic factor X activation was compared with their effect in prothrombin activation. Compared with unstimulated platelets, platelets triggered by the combined action of collagen plus thrombin showed a tenfold activity increase in prothrombin activation, and a 20-fold rate enhancement in factor X activation. Treatment of collagen plus thrombin-stimulated platelets with N.naja phospholipase A2 almost completely abolished their activity in prothrombin and factor X activation. Since no significant cell lysis occurs during phospholipase treatment, this indicates that platelet phospholipids, exposed at the membrane exterior, play an essential role in the interaction of platelets with the proteins of the prothrombin and factor X-activating complexes. The time course of generation of the procoagulant platelet surface was different when the amount of coagulation factors present in the assay systems was varied. At suboptimal concentrations of coagulation factors, maximum platelet activity was reached after a shorter time period than at saturating concentrations. When measured at suboptimal amounts of coagulation factors, the platelet activity in prothrombin and factor X activation is also more sensitive to phospholipase treatment. Experiments with synthetic phospholipid mixtures show that prothrombin and factor X activation are optimal at low mol% phosphatidylserine when high concentrations of factor Va and factor VIIIa are employed. The optimal mol% phosphatidylserine increases when the concentrations of nonenzymatic protein cofactors are lowered. These findings are discussed in relation to a model in which phosphatidylserine, exposed at the outer surface of activated platelets, plays an essential role in prothrombin and factor X activation. It is proposed that this phosphatidylserine is not homogeneously distributed in the platelet outer membrane, but that areas with different phosphatidylserine density participate in coagulation factor activation.

Volume 65, Issue 2, pp. 319-332, 02/01/1985
Copyright © 1985 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. J. Denardo
Exclusive Antiplatelet Therapy for Percutaneous Coronary Intervention
J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1921 - 1922.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Stabile and P. Rubino
Reply
J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1922 - 1922.
[Full Text] [PDF]


Home page
BloodHome page
T.-C. Hsu, K. P. Pratt, and A. R. Thompson
The factor VIII C1 domain contributes to platelet binding
Blood, January 1, 2008; 111(1): 200 - 208.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. L. Wolfs, S. J. Wielders, P. Comfurius, T. Lindhout, J. C. Giddings, R. F. Zwaal, and E. M. Bevers
Reversible inhibition of the platelet procoagulant response through manipulation of the Gardos channel
Blood, October 1, 2006; 108(7): 2223 - 2228.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Kerschbaumer, K. Riedrich, M. Kral, K. Varadi, F. Dorner, J. Rosing, and F. Scheiflinger
An Antibody Specific for Coagulation Factor IX Enhances the Activity of the Intrinsic Factor X-activating Complex
J. Biol. Chem., September 24, 2004; 279(39): 40445 - 40450.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. S. London
The protein kinase C inhibitor RO318220 potentiates thrombin-stimulated platelet-supported prothrombinase activity
Blood, October 1, 2003; 102(7): 2472 - 2481.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. G. Mann, S. Butenas, and K. Brummel
The Dynamics of Thrombin Formation
Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 17 - 25.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Butenas, K. E. Brummel, S. G. Paradis, and K. G. Mann
Influence of Factor VIIa and Phospholipids on Coagulation in "Acquired" Hemophilia
Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 123 - 129.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Szasz and G. L. Dale
Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets
Blood, September 26, 2002; 100(8): 2827 - 2831.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Leo, J. Di Paola, B. A. Judd, G. A. Koretzky, and S. R. Lentz
Role of the adapter protein SLP-76 in GPVI-dependent platelet procoagulant responses to collagen
Blood, September 26, 2002; 100(8): 2839 - 2844.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
Y. Hasumura, N. Aoki, K. Kawano, M. Homori, A. Maki, Y. Hioki, K. Ishikawa, and H. Yoshino
Platelet-Dependent Thrombin Generation in Patients with Unstable Angina Pectoris
Angiology, December 1, 2001; 52(12): 811 - 818.
[Abstract] [PDF]


Home page
BloodHome page
B. N. Y. Setty, A. K. Rao, and M. J. Stuart
Thrombophilia in sickle cell disease: the red cell connection
Blood, December 1, 2001; 98(12): 3228 - 3233.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Undas, K. Brummel, J. Musial, K. G. Mann, and A. Szczeklik
Blood coagulation at the site of microvascular injury: effects of low-dose aspirin
Blood, October 15, 2001; 98(8): 2423 - 2431.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Kamath, A.D. Blann, and G.Y.H. Lip
Platelet activation: assessment and quantification
Eur. Heart J., September 1, 2001; 22(17): 1561 - 1571.
[PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Ilveskero, P. Siljander, and R. Lassila
Procoagulant Activity on Platelets Adhered to Collagen or Plasma Clot
Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 628 - 635.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. S. Ahmad, J. M. Scandura, and P. N. Walsh
Structural and Functional Characterization of Platelet Receptor-mediated Factor VIII Binding
J. Biol. Chem., April 21, 2000; 275(17): 13071 - 13081.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Alberio, O. Safa, K. J. Clemetson, C. T. Esmon, and G. L. Dale
Surface expression and functional characterization of alpha -granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin
Blood, March 1, 2000; 95(5): 1694 - 1702.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Merten, R. Pakala, P. Thiagarajan, and C. R. Benedict
Platelet Microparticles Promote Platelet Interaction With Subendothelial Matrix in a Glycoprotein IIb/IIIa–Dependent Mechanism
Circulation, May 18, 1999; 99(19): 2577 - 2582.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
E. Bevers, P. Comfurius, D. Dekkers, M. Harmsma, and R. Zwaal
Review : Regulatory mechanisms of transmembrane phospholipid distributions and pathophysiological implications of transbilayer lipid scrambling
Lupus, January 1, 1998; 7(2_suppl): S126 - S131.
[Abstract] [PDF]


Home page
CirculationHome page
R. Nieuwland, R. J. Berckmans, R. C. Rotteveel-Eijkman, K. N. Maquelin, K. J. Roozendaal, P. G. M. Jansen, K. t. Have, L. Eijsman, C. E. Hack, and A. Sturk
Cell-Derived Microparticles Generated in Patients During Cardiopulmonary Bypass Are Highly Procoagulant
Circulation, November 18, 1997; 96(10): 3534 - 3541.
[Abstract] [Full Text]


Home page
CirculationHome page
P. Thiagarajan and C. R. Benedict
Inhibition of Arterial Thrombosis by Recombinant Annexin V in a Rabbit Carotid Artery Injury Model
Circulation, October 7, 1997; 96(7): 2339 - 2347.
[Abstract] [Full Text]


Home page
BloodHome page
P. D. Flynn, C. D. Byrne, T. P. Baglin, P. L. Weissberg, and M. R. Bennett
Thrombin Generation by Apoptotic Vascular Smooth Muscle Cells
Blood, June 15, 1997; 89(12): 4378 - 4384.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Bombeli, A. Karsan, J. F. Tait, and J. M. Harlan
Apoptotic Vascular Endothelial Cells Become Procoagulant
Blood, April 1, 1997; 89(7): 2429 - 2442.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. F.A. Zwaal and A. J. Schroit
Pathophysiologic Implications of Membrane Phospholipid Asymmetry in Blood Cells
Blood, February 15, 1997; 89(4): 1121 - 1132.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. P. M. Hayward, E. Furmaniak-Kazmierczak, A.-M. Cieutat, J. C. Moore, D. F. Bainton, M. E. Nesheim, J. G. Kelton, and G. Côté
Factor V Is Complexed with Multimerin in Resting Platelet Lysates and Colocalizes with Multimerin in Platelet alpha-Granules
J. Biol. Chem., August 18, 1995; 270(33): 19217 - 19224.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1985 by American Society of Hematology         Online ISSN: 1528-0020